
SB-225002
CAS No. 182498-32-4
SB-225002( SB225002 )
Catalog No. M12815 CAS No. 182498-32-4
A potent, selective non-peptide CXCR2 antagonist with IC50 of 22 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 39 | In Stock |
![]() ![]() |
10MG | 55 | In Stock |
![]() ![]() |
25MG | 116 | In Stock |
![]() ![]() |
50MG | 213 | In Stock |
![]() ![]() |
100MG | 383 | In Stock |
![]() ![]() |
200MG | 584 | In Stock |
![]() ![]() |
500MG | 888 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameSB-225002
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective non-peptide CXCR2 antagonist with IC50 of 22 nM.
-
DescriptionA potent, selective non-peptide CXCR2 antagonist with IC50 of 22 nM; displays >150-fold selectivity over CXCR1; potently inhibits human and rabbit neutrophil chemotaxis induced by both IL-8 and GROalpha in vitro; selectively blocks IL-8-induced neutrophil margination in rabbits.
-
In Vitro——
-
In Vivo——
-
SynonymsSB225002
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorCXCR2
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number182498-32-4
-
Formula Weight352.1402
-
Molecular FormulaC13H10BrN3O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(NC1=CC=C([N+]([O-])=O)C=C1O)NC2=CC=CC=C2Br
-
Chemical NameUrea, N-(2-bromophenyl)-N'-(2-hydroxy-4-nitrophenyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. White JR, et al. J Biol Chem. 1998 Apr 24;273(17):10095-8.
2. Auten RL, et al. J Pharmacol Exp Ther. 2001 Oct;299(1):90-5.
3. Manjavachi MN, et al. Eur J Pain. 2010 Jan;14(1):23-31.
molnova catalog



related products
-
SCH-546738
SCH-546738 (SCH546738) is a potent, selective and non-competitive CXCR3 antagonist with binding Ki of 0.4 nM for human CXCR3.
-
INCB-3344
A potent, selective and orally bioavailable CCR2 antagonist with IC50 of 5.1 nM and 9.5 nM for hCCR2 and mCCR2, respectively.
-
GSK-2239633
GSK-2239633 is a potent, selective, allosteric CCR4 antagonist with pIC50 of 7.96.